Compare CPHI & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CPHI | FTHM |
|---|---|---|
| Founded | N/A | 2010 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.3M | 31.5M |
| IPO Year | 2008 | 2020 |
| Metric | CPHI | FTHM |
|---|---|---|
| Price | $0.73 | $0.40 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 85.9K | ★ 134.0K |
| Earning Date | 05-11-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.71 |
| EPS | ★ N/A | N/A |
| Revenue | $4,144,268.00 | ★ $420,477,000.00 |
| Revenue This Year | N/A | $11.67 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 25.45 |
| 52 Week Low | $0.38 | $0.41 |
| 52 Week High | $2.05 | $3.37 |
| Indicator | CPHI | FTHM |
|---|---|---|
| Relative Strength Index (RSI) | 48.10 | 21.53 |
| Support Level | $0.52 | N/A |
| Resistance Level | $0.88 | $0.85 |
| Average True Range (ATR) | 0.08 | 0.04 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 12.53 | 12.20 |
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.